8 completed, 2 recruiting, 1 terminated. 11 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 8, Recruiting 2, Terminated 1 |
Follow alvimopan: new trials by email Literature Review of alvimopan trials Research Report on alvimopan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Surgical Techniques During Cystectomy Stent placement, Alvimopan - Bladder Cancer | Phase 3 | Recruiting | Memorial Sloan Kettering Cancer Center | 530 | 2024-11-21 | 2026-09-22 |
| Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol Alvimopan, Placebo - Bladder Cancer | Phase 3 | Recruiting | Brigham and Women's Hospital | 136 | 2018-10-01 | 2023-09-28 |
| Alvimopan as Rescue in Post op Ileus Alvimopan, Control Group - Colorectal Surgery, Ileus | Phase 3 | Terminated | Sharon Stein | 14 | 2015-12-02 | 2022-11-18 |
| Accelerating Gastrointestinal Recovery Alvimopan, Placebo - Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Completed | Jamie N. Bakkum-Gamez | 146 | 2013-01-01 | 2016-10-24 |
| Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain Alvimopan, Placebo - Bowel Dysfunction, Constipation | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 805 | 2005-08-01 | 2017-08-30 |
| Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain Placebo, Alvimopan, Alviompan - Bowel Dysfunction, Constipation | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 485 | 2005-08-01 | 2015-09-02 |
| Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain alvimopan, Placebo - Bowel Dysfunction, Constipation | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 518 | 2005-08-01 | 2015-09-02 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 660 | 2004-06-01 | 2016-01-11 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 510 | 2002-01-01 | 2015-07-20 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus Alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 666 | 2001-12-01 | 2015-07-20 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 451 | 2001-03-01 | 2017-08-22 |
Ileus (5) · Constipation (3) · Intestinal Diseases (3) · Pain (3) · Urinary Bladder Neoplasms (2) · Fallopian Tube Neoplasms (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (7) · Brigham and Women's Hospital (1) · Jamie N. Bakkum-Gamez (1) · Memorial Sloan Kettering Cancer Center (1) · Sharon Stein (1)
United States (11) · Canada (3) · Australia (2) · Austria (2) · Denmark (2) · Finland (2) · Hungary (2) · Ireland (2) · Netherlands (2) · New Zealand (2) · Poland (2) · Spain (2) · Sweden (2) · Switzerland (2) · United Kingdom (2)
Alvin Goh, MD (1) · Jamie Bakkum-Gamez, MD (1) · Mark A Preston, MD (1) · Sharon Stein, MD (1)
PMID 20526599, PMID 15383800, PMID 15906123, PMID 16333556, PMID 19015469, PMID 21292168, PMID 21292169